the major histocompatibility complex
play

The Major Histocompatibility Complex Peter Burrows 2008 4-6529 peterb@uab.edu What it is What it does Required for antigen recognition by T lymphocytes Differences in antigen recognition by B and T lymphocytes T cell

0 downloads 1 Views 496 KB Size Report
  1. The Major Histocompatibility Complex Peter Burrows 2008 4-6529 peterb@uab.edu • What it is • What it does – Required for antigen recognition by T lymphocytes Differences in antigen recognition by B and T lymphocytes • T cell antigen receptor • B cell antigen receptor – Immunoglobulin (Ig) – T cell receptor (TCR) – B cells – T cells Transmembrane protein Transmembrane protein – Secreted by effector cells – Transmembrane protein (Plasma cell) on effector cells – CD4 Helper T Cells – CD8 Cytotoxic T Cells

  2. Review of Differences in T and B Cells • B cells – Recognize native protein antigens in solution or on cell surfaces – Secreted antibody is effector molecule – Antibodies can operate at a distance Antigen-antibody Interaction Heavy Chain Lysozyme Antigenic Determinant Light Chain Epitope

  3. Review of Differences in T and B Cells • B cells • T cells – Recognize native – Recognize peptides from protein antigens in degraded antigens solution or on cell – Peptides are displayed on surfaces cell surfaces in association – Secreted antibody is with specialized proteins effector molecule (MHC) – Antibodies can operate at a distance Proteases TCR #1 TCR #2 Lysozyme

  4. T cells recognize processed (degraded) protein antigens TCR 2 Why? Review of Differences in T and B Cells • B cells • T cells – Recognize native – Recognize peptides from protein antigens in degraded antigens solution or on cell – Peptides are displayed on surfaces cell surfaces in association – Secreted antibody is with specialized proteins effector molecule (MHC) – Antibodies can – Antigen-specific T cell operate at a functions require direct cell ⇔ cell interactions distance

  5. Major Histocompatibility Complex • Discovered using inbred strains of mice and examining tumor immunity • Were really studying transplantation immunology – histocompatibility antigens • MHC is the major histocompatibility antigen that needs to be matched for organ transplantation • A complex of linked genes encodes the MHC proteins • Normal function of MHC is to display peptide antigens (self AND non-self) to T cells MHC • MHC I and MHC II – Genes – Structure – Polymorphisms • MHC and T cell responses

  6. MHC Class I • Expressed by all nucleated cells • Presents peptide to CD8 T cells – Cytotoxic “killer” cells – Kill virus infected cells MHC Class II • Expressed by specialized antigen presenting cells (APC) – Dendritic cells – B cells – Macrophages • Presents peptide to CD4 T cells • “Helper” T cells – Help B cells proliferate, differentiate, isotype switch – Help activate macrophages to kill intracellular pathogens

  7. Helper CD4 T cells MHC Class II Class I

  8. Class I and Class II MHC Molecules • Membrane bound glycoproteins • Structurally very similar • Both have 4 domains – 2 membrane proximal domains – 2 membrane distal domains that form a peptide binding cleft 3-D Structure of Human Class I HLA Molecule

  9. Peptides in the MHC groove

  10. B Cell Class I Help! Class II Self peptide Foreign peptide BCR B B Cell Cell TCR Class I Class II Self peptide Foreign peptide

  11. MHC Polymorphisms • Allelic variations in MHC genes • Concentrated in the peptide binding regions of Class I and Class II

  12. MHC Polymorphisms The human MHC gene complex HLA – human leukocyte antigen

  13. MHC Polymorphisms • Allelic variations in MHC genes • Concentrated in the peptide binding regions of Class I and Class II • Population level • Individual will inherit 9 maternal and 9 paternal MHC genes No gene rearrangements • All are expressed with the MHC! Consequences of MHC Polymorphism • Organ and tissue transplants are difficult • Polymorphic residues change the peptide binding specificity of the MHC • If all MHC were identical, pathogens might avoid immune detection by mutation to prevent MHC binding

  14. Why have two antigen recognition systems? Tc Tc

Recommend Documents


the major histocompatibility complex histocompatibility
The Major Histocompatibility Complex

The Major Histocompatibility Complex Histocompatibility Complex (MHC) (MHC)

hla in health and disease mhc hc
HLA IN HEALTH AND DISEASE MHC HC

HLA IN HEALTH AND DISEASE MHC HC MHC.( Major histocompatibility complex.)

best of both worlds how can this be mhc assortative
Best of both worlds? How can this be?

Best of both worlds? How can this be? MHC-assortative facial preferences in

mhc peptide interaction studies using bioinformatics tools
MHC-Peptide Interaction Studies using

MHC-Peptide Interaction Studies using Bioinformatics tools Presented by

the major hi stocompati bi li ty complex amp anti gen
The MAJOR HI STOCOMPATI BI LI TY

The MAJOR HI STOCOMPATI BI LI TY COMPLEX & ANTI GEN PRESENTATI ON MHC

adding hla dqa1 unacceptable antigen equivalences table
Adding HLA DQA1 Unacceptable Antigen

Adding HLA DQA1 Unacceptable Antigen Equivalences Table Histocompatibility

overview of complex systems
Overview of Complex Systems

Overview Overview of Complex Systems Orientation Principles of Complex

innovative ex vivo protocols to substantiate the anti
INNOVATIVE EX VIVO PROTOCOLS TO

1 INNOVATIVE EX VIVO PROTOCOLS TO SUBSTANTIATE THE ANTI -POLLUTION CLAIM 2

why complex valued
Why Complex-Valued When Are

Fuzzy Logic: Reminder From the . . . From the Intuitive . . . Fuzzy Data . .

ne na ns sg tc
NE NA NS SG TC Major Major Major

The Department of Management (MT ) An exciting place to work August 2014

forget moonshots biomedicine needs an air traffic control
Forget Moonshots Biomedicine Needs an

Forget Moonshots Biomedicine Needs an Air Traffic Control System Jeff

5529 adxs11 001 immunotherapy 12 month survival and
5529 ADXS11-001 IMMUNOTHERAPY: 12

5529 ADXS11-001 IMMUNOTHERAPY: 12 MONTH SURVIVAL AND SAFETY DATA FROM A

with deep learning
with deep learning Mikhail Ignatov,

Designing cancer vaccines with deep learning Mikhail Ignatov, Applied

molecular determinants of factor viii immunogenicity
Molecular determinants of factor VIII

Molecular determinants of factor VIII immunogenicity Moderator Prof. dr.

cdc public health grand rounds
CDC PUBLIC HEALTH GRAND ROUNDS Changes

CDC PUBLIC HEALTH GRAND ROUNDS Changes in Clinical Diagnostics and Tracking

research day at the capitol
Research Day at the Capitol Poster

Research Day at the Capitol Poster Preparation Presentation Cody Bahavar

particle cell interactions and their
PARTICLE-CELL INTERACTIONS AND THEIR

PARTICLE-CELL INTERACTIONS AND THEIR IMPLICATIONS IN LUNG DEFENSE MECHANISMS

cell communication
Cell Communication Topics 4.1 through

Cell Communication Topics 4.1 through 4.2 Topic 4.1 Cell Communication

immuno oncology applications
Immuno-Oncology Applications Lee S.

Immuno-Oncology Applications Lee S. Schwartzberg, MD, FACP West Clinic, P.C.;

hla alleles in the context of rams in therapy naive
HLA alleles in the context of RAMs in

University of Cologne Institute of Virology HLA alleles in the context of

innovative peptides
Innovative Peptides August 2019 Compa

plc Developing Innovative Peptides August 2019 Compa pany ny overv rview

sergio e baranzini ph d professor department of neurology
Sergio E. Baranzini, Ph.D.

Sergio E. Baranzini, Ph.D. Professor Department of Neurology, UCSF